{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:01:19Z","timestamp":1790874079171,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejpn.2026.07.007","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:39:16Z","timestamp":1784853556000},"page":"A1-A2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reopening the Silk Road for rare neurological diseases"],"prefix":"10.1016","volume":"63","author":[{"given":"Laurent","family":"Servais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2026.07.007_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejpn.2026.06.011","article-title":"The prevalence of spinal muscular atrophy in Kazakhstan and the experience with the national nusinersen treatment program","volume":"63","author":"Jaxybayeva","year":"2026","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2026.07.007_bib2","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200310","article-title":"Spinal muscular atrophy update in best practices: recommendations for diagnosis considerations","volume":"14","author":"Schroth","year":"2024","journal-title":"Neurol., Clin. Pract."},{"issue":"6","key":"10.1016\/j.ejpn.2026.07.007_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamapediatrics.2024.0492","article-title":"SMARTCARE study group, clinical effectiveness of newborn screening for spinal muscular atrophy: a nonrandomized controlled trial","volume":"178","author":"Schwartz","year":"2024","journal-title":"JAMA Pediatr."},{"issue":"6","key":"10.1016\/j.ejpn.2026.07.007_bib4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/22143602241288095","article-title":"SMA NBS world study group, newborn screening programs for spinal muscular atrophy worldwide in 2023","volume":"11","author":"Vr\u0161\u010daj","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2026.07.007_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/dmcn.15286","article-title":"Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening","volume":"65","author":"Dangouloff","year":"2023","journal-title":"Dev. Med. Child Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:14:22Z","timestamp":1790871262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379826000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":5,"alternative-id":["S1090379826000802"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.07.007","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reopening the Silk Road for rare neurological diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}